読み込み中
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$612.05
+$9.35 · +1.55%
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
前日終値
$612.05
+$9.35 · +1.55%
日中の時刻はETです。市場データは遅延する場合があります。
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
日中レンジ
現在 $612.05
52週レンジ
現在 $612.05
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
74
割安
センチメント
59
まちまち
リスク
35
中程度のリスク
モメンタム
51
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
日中レンジ
現在 $612.05
52週レンジ
現在 $612.05
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 25.3億 USD | 21.09億 USD | 18.86億 USD | 14.6億 USD | 11.42億 USD |
| 売上原価 | 17.7億 USD | 14.53億 USD | 13.61億 USD | 10.28億 USD | 8.14億 USD |
| 粗利益 | 7.61億 USD | 6.56億 USD | 5.25億 USD | 4.32億 USD | 3.28億 USD |
| 販売・一般管理 | 1.98億 USD | 1.8億 USD | 1.61億 USD | 1.31億 USD | 1.08億 USD |
| 営業費用 | 2.26億 USD | 2.09億 USD | 1.88億 USD | 1.54億 USD | 1.3億 USD |
| 受取利息 | — | 2499.6万 USD | — | — | — |
| 支払利息 | — | — | 48.8万 USD | 290.5万 USD | 10.5万 USD |
| 減価償却費と償却費 | 2812.4万 USD | 2925.1万 USD | 2632.8万 USD | 2234.1万 USD | 2111.9万 USD |
| 営業利益 | 5.35億 USD | 4.47億 USD | 3.37億 USD | 2.79億 USD | 1.99億 USD |
| 純利益 | 4.51億 USD | 4.04億 USD | 2.83億 USD | 2.45億 USD | 1.82億 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI4.31億0.02%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB3.12億0.17%1853億 USD0.03%$289.48+0.64%
Invesco S&P MidCap Quality ETFXMHQ2億3.68%54.37億 USD0.30%$114.23+0.50%
Vanguard Morningstar Small-Cap Growth ETFVBK1.79億0.39%447億 USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF1.56億0.16%954億 USD0.05%$235+0.80%
iShares Biotechnology ETFIBB1.05億1.00%108.2億 USD0.44%$206.49+3.00%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY1.02億0.40%258.17億 USD0.23%$669.87+0.54%
iShares Russell Mid-Cap Growth ETFIWP7652.6万0.39%200.95億 USD0.23%$143.1+1.56%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBInvesco S&P MidCap Quality ETFXMHQVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Biotechnology ETFIBBState Street SPDR S&P MIDCAP 400 ETF TrustMDYiShares Russell Mid-Cap Growth ETFIWPAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
